Dr. Zhiyuan Xu 徐志远
Chief Physician, Associate Professor
Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of gastric cancer, cardia cancer, and various gastric tumors. Specializes in open and minimally invasive surgery, function-preserving gastric surgery, and management of peritoneal and liver metastases.
Dr. Xu is Chief Physician, Professor, and Doctoral Supervisor in the Department of Gastric Surgery. Holding a doctorate in surgery, Dr. Xu specializes in selecting appropriate open or minimally invasive procedures, with expertise in function-preserving gastric surgery. Recognized as a Zhejiang "Innovative Talent," Dr. Xu has received awards for surgical video competitions.
Professional roles
- Vice Chair, Gastric Cancer Professional Committee, Zhejiang Anti-Cancer Association
- Vice Chair, Tumor Nutrition and Support Professional Committee, Zhejiang Anti-Cancer Association
- Standing Committee Member, Gastric Cancer Professional Committee, Zhejiang Society of Mathematical Medicine
- Youth Member, Gastric Cancer Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Xu Zhiyuan). Papers usually list the name as Zhiyuan Xu or Xu Z.
Selected publications
106 papers on PubMed matched by name and affiliation; 29 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biochim Biophys Acta Rev Cancer, 2026 (senior author): Perineural invasion in gastrointestinal malignancies: From neurotrophic signaling to targetable tumor-microenvironment crosstalk. PubMed 42303185
- Cancer Cell, 2026 (first author): Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial. PubMed 42456653
- J Gastric Cancer, 2026 (senior author): Radiomics in Gastric Cancer: Advancing Precision Medicine. PubMed 42411161
- Surgery, 2026 (senior author): Tumor location stratifies lymph node metastasis risk and prognosis in gastric cancer: A retrospective analysis of multicenter data and SEER database. PubMed 41861432
- J Gastrointest Cancer, 2026 (senior author): Therapeutic Value of Dissecting Distal Lymph Nodes in Proximal Gastric Cancer: A TVI-Based Risk Stratification. PubMed 41801519
- Sci Bull (Beijing), 2026 (first author): Comprehensive single-cell profiling uncovers TsMHC-II expression predicting response to neoadjuvant immunotherapy in gastric cancer. PubMed 41558936
- BMC Surg, 2026 (senior author): Application value of Stomach Hanging Maneuver (SHM) in supra-pancreatic lymph node dissection of Laparoscopic Radical Gastrectomy for Upper Gastric Cancer (LRG-UGC). PubMed 41491681
- J Gastroenterol, 2025 (senior author): Inhibition of integrin α3 suppresses gastric cancer progression via STAT3-mediated regulation of SLC1A5-dependent glutamine uptake. PubMed 41060436
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion